Status:
COMPLETED
Blood Sparing Strategies: Single Shot High Dose Erythropoietin Two Days Before Heart Surgery
Lead Sponsor:
Cardiochirurgia E.H.
Conditions:
Blood Transfusion
Eligibility:
All Genders
Phase:
NA
Brief Summary
All patients operated on at the European Hospital Heart surgery Division will be randomized to either single dose 80.000 UI of Human Recombinant Erythropoietin and intravenous iron or control. Primar...
Detailed Description
Growing evidence points out blood transfusion as a major determinant in medium and long term prognosis as regarding heart surgery population. Moreover blood has become a scarce resource, thus often de...
Eligibility Criteria
Inclusion
- All comers
Exclusion
- None
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT01265680
Start Date
February 1 2012
End Date
January 1 2013
Last Update
April 8 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
European Hospital
Rome, Italy, 00149